For cancers lacking identifiable mutations in direct regulators of H3K27me3 (i.e., cancers with EZH2 gain or loss of function or H3.3 K27M mutations), H3K27me3-patterning mechanisms might be responsible for driving aberrant DNA hypermethylation and directly or indirectly tumor initiation or promotion. Here, EZH2 is linked to neoplasm.